Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:59 AM
Ignite Modification Date:
2025-12-25 @ 12:59 AM
NCT ID:
NCT06492993
Eligibility Criteria:
Inclusion Criteria:
* Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and lifestyle considerations (see Section 5.3, Lifestyle Considerations) and availability for the duration of the study
Male or female at birth age 45-80yo or female at birth age 45-80yo; age-eligible according to screening criteria
Self-reported diagnosis of bilateral hearing loss at birth or prior to 13 years old (defined as "early deafness") and use ASL
Willingness to adhere to the CHN clinical trial regimen
Willingness to provide cancer screening verification documentation; this will be reviewed during the informed consent procedure
Access to necessary resources to support video-based communication
Non-adherent to one or more cancer screening guidelines for breast, lung, prostate, colon, cervical cancers will be those who reported not having had the appropriate recommended screenings within the past year to cancer screening questions in the HINTS-ASL survey
Exclusion Criteria:
* Presence of full ability to hear in one or both ears beyond 13 years of age
Younger or older than the age cutoff for the recommended cancer screening
Not capable of independently conducting the activities of daily living
In compliance with age- or risk-specific screening at the time of evaluation for study eligibility
Are currently undergoing cancer treatment or being evaluated for the presence of cancer at the time of evaluation for study eligibility
Will be engaged in more than 21 consecutive days of travel during the eleven-month study window
Knows other participants at baseline
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
45 Years
Maximum Age:
80 Years
Study:
NCT06492993
Study Brief:
Protocol Section:
NCT06492993